Phibro Animal Health Corporation (PAHC) Operating Margin
- Operating margin · 12 months: Value 12.81%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 12.81% | Operating income / revenue. Period ending 2026-06-30. $194.40M ÷ $1.52B × 100 ≈ 12.81% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 194.40M USD | Operating Income (Loss) |
| Revenue | 1.52B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 1.01B USD | Cost of Goods and Services Sold |
| Research and development | 24.55M USD | Research and Development Expense |
| Selling, general and administration | 318.12M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $194.40M | $1.52B | $1.01B | $24.55M | $318.12M | 12.81% |
| 2026-03-31 | $179.96M | $1.50B | $1.01B | (m) | $308.17M | 12.00% |
| 2025-12-31 | $168.82M | $1.46B | $997.31M | (m) | $298.20M | 11.53% |
| 2025-09-30 | $144.03M | $1.40B | $963.45M | (m) | $292.20M | 10.29% |
| 2025-06-30 | $110.47M | $1.30B | $896.27M | $23.73M | $289.48M | 8.52% |
| 2025-03-31 | $95.16M | $1.19B | $813.60M | (m) | $281.92M | 7.99% |
| 2024-12-31 | $81.57M | $1.11B | $753.97M | (m) | $270.54M | 7.37% |
| 2024-09-30 | $71.74M | $1.05B | $717.90M | (m) | $257.12M | 6.85% |
| 2024-06-30 | $53.31M | $1.02B | $704.59M | $29.19M | $259.78M | 5.24% |
| 2024-03-31 | $58.66M | $999.56M | $696.96M | (m) | $243.94M | 5.87% |
| 2023-12-31 | $57.29M | $982.01M | $683.47M | (m) | $241.25M | 5.83% |
| 2023-09-30 | $57.44M | $976.72M | $679.40M | (m) | $239.88M | 5.88% |
| 2023-06-30 | $71.85M | $977.89M | $679.65M | $24.39M | $226.39M | 7.35% |
| 2023-03-31 | $70.97M | $978.11M | $678.11M | (m) | $229.03M | 7.26% |
| 2022-12-31 | $71.61M | $972.05M | $675.97M | (m) | $224.47M | 7.37% |
| 2022-09-30 | $78.06M | $960.12M | $670.75M | (m) | $211.31M | 8.13% |
| 2022-06-30 | $78.99M | $942.26M | $656.86M | $20.83M | $206.41M | 8.38% |
| 2022-03-31 | $75.26M | $907.27M | $630.47M | (m) | $201.55M | 8.29% |
| 2021-12-31 | $76.20M | $879.38M | $605.04M | (m) | $198.15M | 8.66% |
| 2021-09-30 | $73.79M | $852.82M | $580.88M | (m) | $198.14M | 8.65% |
| 2021-06-30 | $74.87M | $833.35M | $561.97M | $17.76M | $196.51M | 8.98% |
| 2021-03-31 | $73.83M | $798.96M | $536.84M | (m) | $188.28M | 9.24% |
| 2020-12-31 | $75.02M | $797.97M | $535.47M | (m) | $187.48M | 9.40% |
| 2020-09-30 | $74.73M | $805.83M | $542.49M | (m) | $188.60M | 9.27% |
| 2020-06-30 | $69.19M | $800.35M | $543.47M | $13.74M | $187.69M | 8.65% |
| 2020-03-31 | $63.17M | (m) | $556.73M | (m) | $198.45M | (m) |
| 2019-12-31 | $64.42M | (m) | $556.41M | (m) | $192.52M | (m) |
| 2019-09-30 | $70.52M | (m) | $561.08M | (m) | $185.96M | (m) |
| 2019-06-30 | $83.23M | (m) | $563.37M | $12.08M | $181.40M | (m) |
| 2019-03-31 | $97.24M | $835.90M | $569.07M | (m) | $169.59M | 11.63% |
| 2018-12-31 | $101.16M | $839.07M | (m) | (m) | $169.87M | 12.06% |
| 2018-09-30 | $99.39M | $826.72M | $557.42M | (m) | $169.91M | 12.02% |
| 2018-06-30 | $98.93M | $819.98M | $553.10M | $10.00M | $167.95M | 12.06% |
| 2018-03-31 | $96.34M | $803.03M | (m) | (m) | $166.16M | 12.00% |
| 2017-12-31 | $99.82M | $783.98M | (m) | (m) | $154.23M | 12.73% |
| 2017-09-30 | $98.51M | $769.71M | (m) | (m) | $152.12M | 12.80% |
| 2017-06-30 | $97.93M | $764.28M | (m) | $9.44M | $150.31M | 12.81% |
| 2017-03-31 | $94.51M | $758.62M | (m) | (m) | $150.18M | 12.46% |
| 2016-12-31 | $85.71M | $752.22M | (m) | (m) | $157.15M | 11.39% |
| 2016-09-30 | $85.70M | $752.39M | (m) | (m) | $155.13M | 11.39% |
| 2016-06-30 | $85.74M | $751.53M | (m) | $11.03M | $153.29M | 11.41% |
| 2016-03-31 | $86.61M | $747.30M | (m) | (m) | $156.77M | 11.59% |
| 2015-12-31 | $87.25M | $751.34M | (m) | (m) | $155.28M | 11.61% |
| 2015-09-30 | $84.42M | $748.25M | (m) | (m) | $151.78M | 11.28% |
| 2015-06-30 | $87.67M | $748.59M | (m) | $9.51M | $148.70M | 11.71% |
| 2015-03-31 | $79.76M | $747.32M | (m) | (m) | $150.03M | 10.67% |
| 2014-12-31 | $75.27M | $733.09M | (m) | (m) | $148.25M | 10.27% |
| 2014-09-30 | $72.50M | $717.14M | (m) | (m) | $146.09M | 10.11% |
| 2014-06-30 | $63.79M | $691.91M | (m) | $8.21M | $143.98M | 9.22% |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $62.78M | $661.86M | (m) | (m) | $131.80M | 9.49% |
| 2013-09-30 | $59.92M | $653.27M | (m) | (m) | $126.69M | 9.17% |
| 2013-06-30 | $56.73M | $653.15M | (m) | $6.64M | $122.23M | 8.69% |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $49.33M | $654.10M | (m) | $7.19M | $114.81M | 7.54% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.